Baillie Gifford & Co’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-7,428
Closed -$321K 213
2015
Q3
$321K Buy
7,428
+639
+9% +$27.6K ﹤0.01% 190
2015
Q2
$287K Sell
6,789
-55
-0.8% -$2.33K ﹤0.01% 191
2015
Q1
$265K Buy
6,844
+391
+6% +$15.1K ﹤0.01% 195
2014
Q4
$217K Buy
6,453
+4,020
+165% +$135K ﹤0.01% 194
2014
Q3
$85K Buy
+2,433
New +$85K ﹤0.01% 200